scispace - formally typeset
A

Azin Mirzazadeh

Researcher at University of Arkansas for Medical Sciences

Publications -  9
Citations -  258

Azin Mirzazadeh is an academic researcher from University of Arkansas for Medical Sciences. The author has contributed to research in topics: Acute kidney injury & Nephropathy. The author has an hindex of 5, co-authored 9 publications receiving 141 citations. Previous affiliations of Azin Mirzazadeh include Shahid Sadoughi University of Medical Sciences and Health Services.

Papers
More filters
Journal ArticleDOI

Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection

TL;DR: The most critical findings related to the genetics of the SARS-CoV-2 are reviewed, with a specific focus on genetic diversity and reported mutations, molecular-based diagnosis assays, using interfering RNA technology for the treatment of patients, and genetic-related vaccination strategies.
Journal ArticleDOI

Coronavirus-nephropathy; renal involvement in COVID-19

TL;DR: Renal disturbances by coronavirus disease 2019 (COVID-19), consisted of acute kidney injury, due to acute tubular necrosis induced by sepsis, hydration, cytokine storm syndrome, rhabdomyolysis and hypoxia, and special attention should be paid to control of classical risk factors of kidney injury.
Journal ArticleDOI

Clinical display, diagnostics and genetic implication of novel Coronavirus (COVID-19) epidemic.

TL;DR: The role of HLA haplotype in virus infection as HLA typing will provide susceptibility information for personalized prevention, diagnosis, and treatment in future studies is highlighted.
Journal ArticleDOI

Single-nucleotide polymorphisms associated with pemphigus vulgaris: Potent markers for better treatment and personalized medicine

TL;DR: It was found that several SNPs in different genes might control the susceptibility of PV, including TNFA, and variations in the other genes involved in the drugs' metabolisms, pharmacokinetics and pharmacodynamics could be used for the prediction of clinical response to drugs and side effects.